BR112012032889A2 - preparação do ácido 13-ciclo-hexil-3-metóxi-6-[metil-(2-{2-[metil-(sulfamoil)-amino]-etóxi}-etil)-carbamoil]-7h-indol-[2,1-a]-[2]-benzazepina-10-carboxílico - Google Patents
preparação do ácido 13-ciclo-hexil-3-metóxi-6-[metil-(2-{2-[metil-(sulfamoil)-amino]-etóxi}-etil)-carbamoil]-7h-indol-[2,1-a]-[2]-benzazepina-10-carboxílicoInfo
- Publication number
- BR112012032889A2 BR112012032889A2 BR112012032889A BR112012032889A BR112012032889A2 BR 112012032889 A2 BR112012032889 A2 BR 112012032889A2 BR 112012032889 A BR112012032889 A BR 112012032889A BR 112012032889 A BR112012032889 A BR 112012032889A BR 112012032889 A2 BR112012032889 A2 BR 112012032889A2
- Authority
- BR
- Brazil
- Prior art keywords
- methyl
- sulfamoyl
- ethoxy
- ethyl
- benzazepine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C307/00—Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C307/04—Diamides of sulfuric acids
- C07C307/06—Diamides of sulfuric acids having nitrogen atoms of the sulfamide groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Indole Compounds (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10167221 | 2010-06-24 | ||
PCT/EP2011/060606 WO2011161232A1 (en) | 2010-06-24 | 2011-06-24 | PREPARATION OF 13-CYCLOHEXYL-3-METHOXY-6-[METHYL-(2-{2-[METHYL-(SULPHAMOYL)-AMINO]-ETHOXY}-ETHYL)-CARBAMOYL]-7H-INDOLO-[2,1-a]-[2]-BENZAZEPINE-10-CARBOXYLIC ACID |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012032889A2 true BR112012032889A2 (pt) | 2015-09-15 |
Family
ID=43216626
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012032889A BR112012032889A2 (pt) | 2010-06-24 | 2011-06-24 | preparação do ácido 13-ciclo-hexil-3-metóxi-6-[metil-(2-{2-[metil-(sulfamoil)-amino]-etóxi}-etil)-carbamoil]-7h-indol-[2,1-a]-[2]-benzazepina-10-carboxílico |
Country Status (11)
Country | Link |
---|---|
US (2) | US9127010B2 (pt) |
EP (1) | EP2585438B1 (pt) |
JP (1) | JP5870098B2 (pt) |
CN (1) | CN103097356B (pt) |
AU (1) | AU2011268922B2 (pt) |
BR (1) | BR112012032889A2 (pt) |
CA (1) | CA2801517C (pt) |
IL (1) | IL223427A (pt) |
MX (1) | MX2012015198A (pt) |
RU (1) | RU2559886C2 (pt) |
WO (1) | WO2011161232A1 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI454476B (zh) | 2008-07-08 | 2014-10-01 | Tibotec Pharm Ltd | 用作c型肝炎病毒抑制劑之巨環吲哚衍生物 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6054472A (en) | 1996-04-23 | 2000-04-25 | Vertex Pharmaceuticals, Incorporated | Inhibitors of IMPDH enzyme |
US5807876A (en) | 1996-04-23 | 1998-09-15 | Vertex Pharmaceuticals Incorporated | Inhibitors of IMPDH enzyme |
CZ298463B6 (cs) | 1996-04-23 | 2007-10-10 | Vertex Pharmaceuticals Incorporated | Deriváty mocoviny pro použití jako inhibitory IMPDH enzymu a farmaceutické prostredky, které je obsahují |
DK0966465T3 (da) | 1997-03-14 | 2003-10-20 | Vertex Pharma | Inhibitorer af IMPDH-enzymer |
ES2405316T3 (es) | 1999-03-19 | 2013-05-30 | Vertex Pharmaceuticals Incorporated | Inhibidores de la enzima IMPDH |
WO2002019369A1 (fr) | 2000-08-30 | 2002-03-07 | Matsushita Electric Industrial Co., Ltd. | Unite d'affichage a plasma et son procede de fabrication |
US7153848B2 (en) | 2004-08-09 | 2006-12-26 | Bristol-Myers Squibb Company | Inhibitors of HCV replication |
KR20080040032A (ko) | 2005-09-02 | 2008-05-07 | 티보텍 파마슈티칼즈 리미티드 | Hcv 저해제로서의 벤조디아제핀 |
US7399758B2 (en) | 2005-09-12 | 2008-07-15 | Meanwell Nicholas A | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
GB0522881D0 (en) | 2005-11-10 | 2005-12-21 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
WO2007092000A1 (en) | 2006-02-06 | 2007-08-16 | Bristol-Myers Squibb Company | Inhibitors of hcv replication |
US7456166B2 (en) | 2006-05-17 | 2008-11-25 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
US7521443B2 (en) | 2006-05-17 | 2009-04-21 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
US7521441B2 (en) | 2006-05-22 | 2009-04-21 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
US7521442B2 (en) * | 2006-05-25 | 2009-04-21 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
US8101595B2 (en) | 2006-12-20 | 2012-01-24 | Istituto di Ricerche di Biologia Molecolare P. Angletti SpA | Antiviral indoles |
AU2008277440A1 (en) | 2007-07-17 | 2009-01-22 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa | Macrocyclic indole derivatives for the treatment of hepatitis C infections |
TWI454476B (zh) * | 2008-07-08 | 2014-10-01 | Tibotec Pharm Ltd | 用作c型肝炎病毒抑制劑之巨環吲哚衍生物 |
-
2011
- 2011-06-24 MX MX2012015198A patent/MX2012015198A/es active IP Right Grant
- 2011-06-24 US US13/805,607 patent/US9127010B2/en not_active Expired - Fee Related
- 2011-06-24 CA CA2801517A patent/CA2801517C/en not_active Expired - Fee Related
- 2011-06-24 RU RU2013103004/04A patent/RU2559886C2/ru not_active IP Right Cessation
- 2011-06-24 CN CN201180030949.0A patent/CN103097356B/zh not_active Expired - Fee Related
- 2011-06-24 EP EP11727184.1A patent/EP2585438B1/en not_active Not-in-force
- 2011-06-24 WO PCT/EP2011/060606 patent/WO2011161232A1/en active Application Filing
- 2011-06-24 JP JP2013515907A patent/JP5870098B2/ja not_active Expired - Fee Related
- 2011-06-24 AU AU2011268922A patent/AU2011268922B2/en not_active Ceased
- 2011-06-24 BR BR112012032889A patent/BR112012032889A2/pt not_active IP Right Cessation
-
2012
- 2012-12-04 IL IL223427A patent/IL223427A/en active IP Right Grant
-
2015
- 2015-07-28 US US14/810,783 patent/US20150329482A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2585438B1 (en) | 2014-08-20 |
MX2012015198A (es) | 2013-02-11 |
US20130102777A1 (en) | 2013-04-25 |
WO2011161232A1 (en) | 2011-12-29 |
RU2013103004A (ru) | 2014-07-27 |
JP2013530976A (ja) | 2013-08-01 |
AU2011268922A1 (en) | 2013-01-10 |
CN103097356B (zh) | 2016-01-13 |
RU2559886C2 (ru) | 2015-08-20 |
US20150329482A1 (en) | 2015-11-19 |
US9127010B2 (en) | 2015-09-08 |
CA2801517C (en) | 2017-12-12 |
CN103097356A (zh) | 2013-05-08 |
IL223427A (en) | 2015-04-30 |
CA2801517A1 (en) | 2011-12-29 |
JP5870098B2 (ja) | 2016-02-24 |
AU2011268922B2 (en) | 2014-06-12 |
EP2585438A1 (en) | 2013-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1124874T1 (el) | Διεργασια για την παρασκευη [(5-(3-χλωροφαινυλ)-3-υδροξυπυριδινο-2-καρβονυλ)-αμινο]οξικου οξεος απο 5-((3-χλωροφαινυλ)-3-χλωρο-πυριδιν-2-υλ)-νιτριλιο, και διεργασια για την παρασκευη παραγωγων 5-((αλογονοφαινυλ)-3-αλογονο-πυριδιν-2-υλ)-νιτριλιου | |
WO2010128516A3 (en) | Process for the preparation of flibanserin involving novel intermediates | |
ME01618B (me) | Novi proces za dobijanje derivata aminokiselina | |
GT201200280A (es) | Procedimiento | |
CR20130556A (es) | FORMULACIÓN PARA ANTICUERPO ANTI-a4ß7 | |
AR075291A1 (es) | Proceso para la preparcion de derivados de l-alanina protegidos | |
WO2012056458A3 (en) | Intermediate compounds and process for the preparation of fingolimod | |
BRPI0905147A8 (pt) | processo para síntese de ivabradina e seus sais de adição com um ácido farmaceuticamente aceitável | |
BRPI0921013A2 (pt) | processo para a síntese de um ômega-aminoácido (éster). | |
BR112013023471A2 (pt) | cocristal de n-[2-(7-metóxi-1-naftil) etil]acetamina, e, processo para preparar um cocristal. | |
EA201201082A1 (ru) | Фармацевтическая композиция, содержащая n-(2-хлор-6-метилфенил)-2-[[6-[4-(2-гидроксиэтил)-1-пиперазинил]-2-метил-4-пиримидинил]амино]-5-тиазолкарбоксамид | |
BR112012006406A2 (pt) | "processo para a fabrição de n-acilbifenil alanina" | |
CR10206A (es) | Acidos4-fenil-tiazol-5-carboxilicos amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1 | |
WO2007106879A3 (en) | Process for preparing n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide and related metabolites thereof | |
CL2011001405A1 (es) | Procedimiento para la preparacion de n-[2-(7-metoxi-1-naftil)etil]acetamida, agometalina. | |
UA113615C2 (xx) | Спосіб отримання 2-аміно-n-(2,2,2-трифторетил)ацетаміду | |
RU2011119224A (ru) | СПОСОБ ПОЛУЧЕНИЯ (S)-(-)-2-(N-ПРОПИЛАМИНО)-5-МЕТОКИТЕТРАЛИНА И (S)-(-)-2-(N-ПРОПИЛАМИНО)-5-ГИДРОКСИТЕТРАЛИНА, ИХ СОЛИ С N-3,5-ДИНИТРОБЕНЗОИЛ)-α-ФЕНИЛГЛИЦИНОМ, СПОСОБ ПОЛУЧЕНИЯ (6S)-(-)-5,6,7,8-ТЕТРАГИДРО-6-[ПРОПИЛ(2-ТИЕНИЛ)ЭТИЛ]АМИНО-1-НАФТОЛА (РОТИГОТИНА) (ВАРИАНТЫ) | |
AR064465A1 (es) | Procesopatra preparar (1r, 2s, 5s) -n- [(1s)]-3- amino-1- ( ciclobutimetil) -2,3- dioxopropil] -3- [2s)-2- [[[(1,1- dimetiletil) amino]- carbonil] amino ]-3,3- dimetil -1- oxobutil] 6,6- dimetil-3- azabicoiclo (3.1.0] hexan -2- carboxamida | |
BR112012032889A2 (pt) | preparação do ácido 13-ciclo-hexil-3-metóxi-6-[metil-(2-{2-[metil-(sulfamoil)-amino]-etóxi}-etil)-carbamoil]-7h-indol-[2,1-a]-[2]-benzazepina-10-carboxílico | |
UY31681A1 (es) | Procedimiento de preparcion de combretastatina | |
MX2010009926A (es) | Nuevo proceso para la preparacion de derivados de acido ciclohexancarboxilico. | |
BR112012022356A2 (pt) | processo para a preparação de 2-(ciclo-hexil-metil)-n-{2-[(2s)-1-metil-pirrolidin-2-il]etil)-1,2,3,4-tetra-hidroisoqunolina-7-suldonamida. | |
BRPI0920896A2 (pt) | composto de fórmula geral ( i ) (t z) n p (i), formula farmacêutica, e processo para preparar um composto de fórmula geral (i) | |
WO2011022429A3 (en) | Process for the preparation of (s)-2-amino-5-cyclopropyl-4,4-difluoropentanoic acid and alkyl esters and acid salts thereof | |
BR112013024564A2 (pt) | método para fazer um corpo de recipiente, e recipiente |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Owner name: JANSSEN SCIENCES IRELAND UC (IE) |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2598 DE 20-10-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |